Secukinumab treatment of plaque psoriasis shows early improvement in DLQI response - results of a phase II regimen-finding trial
about
The Role of IL-17 in the Pathogenesis and Treatment of Psoriasis.Raising Standards for the Evaluation of Future Psoriasis Therapeutics: A Critical Checklist.The Role of IL-17 in the Pathogenesis of Psoriasis and Update on IL-17 Inhibitors for the Treatment of Plaque Psoriasis.Psoriasis patients with psoriasis Area and Severity Index (PASI) 90 response achieve greater health-related quality-of-life improvements than those with PASI 75-89 response: results from two phase 3 studies of secukinumab.No meaningful association between suicidal behavior and the use of IL-17A-neutralizing or IL-17RA-blocking agents.Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis.
P2860
Q33574671-2A0E5FAD-0931-4B93-91AD-C2C6E2878240Q38658837-27D42E82-2130-4F50-AF40-3830B82B4430Q38840275-C618AC47-E6DC-4E99-A5A2-46C5B80173BFQ38925574-0D271177-B9C0-4FE1-9E1B-633FBDFFA6E1Q38935474-44BC1D23-93E1-4CDA-8AA2-A0A6F93C69ACQ47260366-15979E8F-629C-423F-AB77-F5BB46201E6FQ49985388-D431F137-A0F3-45F2-9E16-C17140088F71
P2860
Secukinumab treatment of plaque psoriasis shows early improvement in DLQI response - results of a phase II regimen-finding trial
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Secukinumab treatment of plaqu ...... phase II regimen-finding trial
@en
type
label
Secukinumab treatment of plaqu ...... phase II regimen-finding trial
@en
prefLabel
Secukinumab treatment of plaqu ...... phase II regimen-finding trial
@en
P2093
P2860
P356
P1476
Secukinumab treatment of plaqu ...... phase II regimen-finding trial
@en
P2093
C Papavassillis
M Augustin
S Abeysinghe
P2860
P304
P356
10.1111/JDV.13478
P577
2015-12-10T00:00:00Z